Complete Mounjaro To Wegovy Dose Conversion Guide

pricing for mounjaro and wegovy weight loss

Switching from Mounjaro to Wegovy requires careful dose conversion planning. Both medications work differently—Mounjaro (tirzepatide) is a dual GIP+GLP-1 agonist while Wegovy (semaglutide) targets GLP-1 receptors only. Understanding the equivalent dosing pathway is essential for a smooth transition. Our clinical team at EverydayMeds provides expert guidance for patients considering this switch, with Wegovy starter doses from £79.99. Use discount code FIRST40 for new customers or DOSE25 for returning patients at checkout. This comprehensive conversion chart helps you understand the dosing differences between these prescription-only medicines, ensuring your weight management journey continues effectively with proper medical supervision.

  • Complete dose conversion chart comparing Mounjaro tirzepatide to Wegovy semaglutide equivalents
  • Exclusive discount codes FIRST40 (new customers) and DOSE25 (returning customers) applied at checkout
  • Expert clinical guidance for seamless medication transitions with GPhC-registered pharmacy support
  • Next-day delivery with temperature-controlled storage for immediate treatment continuity
Start your free consultation

Takes less than 2 minutes to complete, 100% online

usp of our everydaymeds for mounjaro and wegovy
pricing for mounjaro and wegovy weight loss

*Pricing shown in some areas of this page may not be up to date. Please refer to the “Our Pricing Table” or the price shown after your consultation for the latest live pricing.

Frame 1321316928.svg__PID:03074d51-9c66-4b1e-ad0f-6a0dc34acdd5
bannrimg.png__PID:519c668b-1ead-4f6a-8dc3-4acdd56dd164
bnr.svg__PID:8b1ead0f-6a0d-434a-8dd5-6dd1641b9de5
Mobile V.png__PID:3e6d948f-9181-4896-be44-1a72380b0bf4
Live Pricing

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date. The live pricing table below and the pricing shown during your consultation are our official current prices and take precedence over any other figures displayed on the site.

first30tag.svg__PID:d76478da-2741-497a-ba1b-d886bd1544e3

Why Patients Switch From Mounjaro To Wegovy

Understanding Mounjaro To Wegovy Dose Conversion Chart Differences

The mounjaro to wegovy dose conversion chart requires understanding fundamental mechanism differences between these prescription-only medicines. Mounjaro contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Wegovy contains semaglutide, which targets GLP-1 receptors exclusively, mimicking natural fullness hormones to reduce appetite and promote satiety after smaller meals.

When reviewing a mounjaro to wegovy dose conversion chart, patients should note that direct milligram-to-milligram conversions aren't clinically appropriate due to different molecular structures and receptor binding profiles. Wegovy follows a specific escalation schedule: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance dosing. Most patients transitioning from Mounjaro typically restart Wegovy's escalation protocol from 0.25mg to ensure tolerability and minimise gastrointestinal side effects.

Discount Code Savings For Mounjaro To Wegovy Conversion

Our mounjaro to wegovy dose conversion chart includes exclusive pricing with discount codes applied at checkout. New customers use code FIRST40, while returning customers apply DOSE25 to access our competitive pricing structure. The Wegovy 0.25mg starter dose costs £79.99, with our Intro Duo bundle (0.25mg and 0.5mg) available for £169.99, providing the first two months of treatment at exceptional value.

Patients following the complete mounjaro to wegovy dose conversion chart pathway can utilise our Getting Started bundles for seamless transitions. The Intro Trio (0.25mg, 0.5mg, and 1mg) costs £299.99, covering the initial three-month escalation period. Our Progress Duo (0.5mg and 1mg) at £189.99 suits patients who've previously tolerated similar GLP-1 medications, though clinical assessment remains essential for appropriate dosing decisions.

Clinical Evidence Supporting Mounjaro To Wegovy Transitions

The mounjaro to wegovy dose conversion chart reflects evidence from the STEP clinical trial programme, where Wegovy demonstrated significant efficacy alongside reduced-calorie diet and increased physical activity. In the pivotal STEP 1 trial, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 5 data showed sustained clinically studied weight loss at two years, supporting long-term treatment approaches.

Patients considering our mounjaro to wegovy dose conversion chart should understand that weight management represents a chronic condition requiring ongoing medical supervision. The SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events (HR 0.80), highlighting potential benefits beyond weight management for eligible patients with established cardiovascular disease.

How Wegovy Works In Your Mounjaro Conversion Plan

Understanding the mounjaro to wegovy dose conversion chart requires knowing how Wegovy functions as a GLP-1 receptor agonist. Wegovy mimics incretin hormones naturally produced in the intestines, signalling the brain's appetite control centres to reduce hunger and increase feelings of fullness after eating smaller portions. This mechanism may help reduce food cravings and emotional eating patterns, supporting adherence to reduced-calorie dietary approaches. The once-weekly FlexTouch pen injection provides consistent therapeutic levels, with effects building gradually during the dose escalation period. Unlike Mounjaro's dual receptor approach, Wegovy's targeted GLP-1 action offers a well-established safety profile with over three years of real-world clinical experience since UK approval.

Ordering Process For Your Mounjaro To Wegovy Transition

Accessing our mounjaro to wegovy dose conversion chart begins with EverydayMeds' streamlined clinical assessment process, taking just three minutes to complete online. Our qualified prescribers review your medical history, current medications, and treatment goals within three working days (express 24-hour service available). Once approved, your Wegovy prescription ships via next-day delivery using temperature-controlled packaging to maintain the medication's stability and efficacy. Our GPhC-registered pharmacy (#9012878) ensures compliance with UK medicines regulations, providing prescription-only medicine access with complete clinical oversight. The entire process from assessment to delivery typically takes 4-5 working days, ensuring minimal treatment interruption during your medication transition.

Storage Advantages In Mounjaro To Wegovy Conversion Planning

The mounjaro to wegovy dose conversion chart includes important storage considerations that may influence your switching decision. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but offer superior travel flexibility with up to six weeks of room temperature storage below 30°C once removed from refrigeration. This represents a significant advantage over Mounjaro's 21-day room temperature limitation, making Wegovy more convenient for business travel, holidays, or lifestyle flexibility. Each FlexTouch pen contains four weekly doses, with clear dosing windows and an easy-to-use injection mechanism. The extended room temperature storage supports better treatment adherence for patients with varying schedules or limited refrigerator access during travel periods.

Personalised Mounjaro To Wegovy Dose Conversion Chart Strategies

Creating your individualised mounjaro to wegovy dose conversion chart requires considering previous treatment responses, tolerability patterns, and current health status. Patients who experienced significant gastrointestinal side effects with Mounjaro may benefit from slower Wegovy escalation, potentially extending the 0.25mg phase beyond the standard four weeks. Our clinical team can recommend Take-It-Slow bundles like the Gentle Start Trio (0.25mg, 0.25mg, 0.5mg) for £269.99, allowing extended adjustment periods.

Advanced users following accelerated mounjaro to wegovy dose conversion chart protocols might consider our Progress Trio (0.5mg, 1mg, 1.7mg) for £369.99, though this requires careful clinical oversight. The key principle remains patient safety and tolerability, with most prescribers recommending standard escalation schedules regardless of previous Mounjaro experience, ensuring optimal outcomes while minimising adverse effects.

Complete Your Mounjaro To Wegovy Conversion Today

Your mounjaro to wegovy dose conversion chart journey starts with EverydayMeds' expert clinical support and competitive pricing structure. Apply discount code FIRST40 at checkout for new customers or DOSE25 for returning patients to access our full Wegovy range from £79.99. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and secure next-day delivery of your prescription-only medicine. Our GPhC-registered pharmacy (#9012878) provides ongoing support throughout your treatment transition, ensuring seamless continuity of care. Don't delay your weight management goals—complete your assessment today and experience the difference professional pharmacy care makes in your therapeutic success.

Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026

How it
Works?

Group 469326.png__PID:d1d71928-56cc-4f79-bdc7-0a45d0bc6b99
Background (1).png__PID:62282697-4455-4e74-a869-705c14f98b30
Background (3).png__PID:72aeaaf6-bb5b-4dd5-8914-6efdf80a1555

Start your assessment for Weight Loss

Start your journey to better health today.

List.svg__PID:b4a5b990-cf62-48e4-ba8f-0a8bffce6cc6

Start your journey to better health today.

Once you complete a short online assessment, you’ll be able to choose your preferred treatment and quantity from a list of safe, medically approved options tailored to you.

Start My Assessment

Returning customer?

Log in to Your Account

Frequently Asked Question